NASDAQ:EWTX | Cash Flow Statement | Edgewise Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$57.33M
2026-03-31-$49.01M-$42.54M$260,000.00$2.43M$12.17M
2025-12-31-$50.22M-$38.59M$73,000.00$49.76M$3.98M
2025-09-30-$40.67M
2025-06-30-$36.12M
2025-03-31-$40.8M-$37.87M$44,000.00$43.9M$2.22M
2024-12-31-$39.66M-$26.96M$274,000.00$20.92M$2.9M
2024-09-30-$34.13M
2024-06-30-$31.5M
2024-03-31-$28.53M-$28.6M$297,000.00-$268.31M$241.07M
2023-12-31-$30.14M-$26.83M$161,000.00$26.98M$52.99M
2023-09-30-$25.71M
2023-06-30-$21.47M
2023-03-31-$22.84M-$22.83M$4.37M$49.04M$21,000.00
2022-12-31-$19.42M-$11.86M$3.29M-$75.6M-$303,000.00
2022-09-30-$17.5M
2022-06-30-$16.07M
2022-03-31-$14.66M-$12.57M$369,000.00$31.39M$73,000.00
2021-12-31-$12.7M-$9.42M$79,000.00$14.12M$293,000.00
2021-09-30-$12.95M
2021-06-30-$10.35M
2021-03-31-$6.82M-$6.06M$62,000.00-$64.77M$186.95M
2020-12-31-$6.34M-$4.64M$0.00-$24.18M$95M
2020-09-30-$3.64M
2020-06-30-$3.95M
2020-03-31-$3.19M-$2.74M$9,000.00-$9,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$167.8M-$143.82M$256,000.00-$32.79M$196.09M
2024-12-31-$133.81M-$109.03M$1.31M-$184.66M$249.25M
2023-12-31-$100.16M-$91.95M$5.75M$102.89M$53.17M
2022-12-31-$67.64M-$52.64M$5.55M-$70.58M$129.64M
2021-12-31-$42.81M-$33.51M$668,000.00-$242.23M$186.38M
2020-12-31-$17.12M-$14.63M$203,000.00-$24.38M$120.28M